ArticlePediatric nephrology (Berlin, Germany)2024

Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.

Shunsuke Yokota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.